Literature DB >> 10694645

Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.

Y L Gong1, G M Xu, W D Huang, L B Chen.   

Abstract

BACKGROUND AND OBJECTIVES: The objective was to evaluate the potent role of matrix metalloproteinases(MMPs) and the tissue inhibitors of metalloproteinases(TIMPs) in processes leading to metastasis and local invasiveness of Chinese human ductal adenocarcinomas of the pancreas. We also evaluated a possible biological association between the gene expression and clinical manifestations.
METHODS: Northern blot and in situ hybridization have shown MMP and TIMP gene expression in the pancreas and alterations associated with neoplastic transformation. Fifteen cases of surgical pancreatic specimens were examined, using cDNA probes to MMP2, MMP9, and TIMP1. Findings were correlated with the size of tumor section, CA19-9, pathological classification, thrombosis, and infiltration of capsule and lymphonoids.
RESULTS: Increased levels of the mRNA of MMP2, MMP9, and TIMP1 genes, MMP2 approximately MMP9<TIMP1, were found in pancreatic cancer tissues examined. Low levels of transcripts for MMP2, MMP9, and TIMP1 were detectable in pancreata of organ donors. Transcripts coding for MMP2, MMP9, and TIMP1 were found in both stroma and tumor cells. However, gene expression of MMP2, MMP9, and TIMP1 has shown an obvious correlation with the infiltration of capsule cells, surrounding lymphonoids and specific histopathological features.
CONCLUSIONS: We concluded that the imbalance between MMPs and TIMPs may help physicians to assess the metastatic potential and then tell the prognosis of individual patients. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694645     DOI: 10.1002/(sici)1096-9098(200002)73:2<95::aid-jso7>3.0.co;2-r

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  21 in total

1.  Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Authors:  Michela Capello; Leonidas E Bantis; Ghislaine Scelo; Yang Zhao; Peng Li; Dilsher S Dhillon; Nikul J Patel; Deepali L Kundnani; Hong Wang; James L Abbruzzese; Anirban Maitra; Margaret A Tempero; Randall Brand; Matthew A Firpo; Sean J Mulvihill; Matthew H Katz; Paul Brennan; Ziding Feng; Ayumu Taguchi; Samir M Hanash
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

2.  Effect of shRNA targeting survivin on ovarian cancer.

Authors:  Jun Xing; Chang-Ru Jia; Yan Wang; Jing Guo; Yan Cai
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-18       Impact factor: 4.553

3.  Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.

Authors:  Vishnu C Ramani; Gur P Kaushal; Randy S Haun
Journal:  Biochim Biophys Acta       Date:  2011-05-17

4.  Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.

Authors:  Y L Gong; C J Tao; M Hu; J F Chen; X F Cao; G M Lv; P Li
Journal:  Curr Oncol       Date:  2012-07       Impact factor: 3.677

5.  The molecular targets for the diagnosis and treatment of pancreatic cancer.

Authors:  Alexios S Strimpakos; Kostas N Syrigos; Muhammad Wasif Saif
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

6.  Human macrophage metalloelastase worsens the prognosis of pancreatic cancer.

Authors:  Peter Balaz; Helmut Friess; Yasuo Kondo; Zhaowen Zhu; Arthur Zimmermann; Markus W Büchler
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  Matrix metalloproteinase-1 promotes muscle cell migration and differentiation.

Authors:  William Wang; Haiying Pan; Kiley Murray; Bahiyyah S Jefferson; Yong Li
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

8.  Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.

Authors:  Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-10       Impact factor: 5.650

9.  Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media.

Authors:  Jing Xiao; Wai-Nang Paul Lee; Yingchun Zhao; Rui Cao; Vay Liang W Go; Robert R Recker; Qi Wang; Gary Guishan Xiao
Journal:  Pancreas       Date:  2010-01       Impact factor: 3.327

10.  Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Samudra Acharya; Hong-Moon Sohn; Jae Yeoul Jun; In-Youb Chang; Ho Jin You
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.